KRT7 and sarcoma: To account for the heterogeneity of sarcomas, we employed antibodies targeting three choices of cell surface proteins: cytokeratin 7/8 (CK), pan-cytokeratin (panCK), and a combination of panCK and CSV (panCK + CSV).